Mesenchymal stem cell sheet transplantation combined with locally released simvastatin enhances bone formation in a rat tibia osteotomy model

Cytotherapy

Volumn 15, Issue 1, 2013, Pages 44-56

  Qi, Yiying ^a   Zhao, Tengfei ^b   Yan, Weiqi ^a   Xu, Kan ^a   Shi, Zhongli ^a   Wang, Jianwei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Fracture; Mesenchymal stem cells; MSC sheet; Nonunion; Simvastatin

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM SULFATE; OSTEOCALCIN; OSTEOPROTEGERIN; OSTEOSET; SIMVASTATIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; CALLUS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FRACTURE HEALING; GENE EXPRESSION; GROWTH CURVE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSSIFICATION; OSTEOTOMY; PRIORITY JOURNAL; PSEUDARTHROSIS; RAT; TIBIA; UPREGULATION;

EID: 84875468083     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.10.006     Document Type: Article

References (41)

1. Einhorn TA. Enhancement of fracture healing. Instr Course Lect. 1996;45:401-16.
2. Rubin C, Bolander M, Ryaby JP, Hadjiargyrou M. The use of low-intensity ultrasound to accelerate the healing of fractures. J Bone Joint Surg Am. 2001;83-A:259-70.
3. Yajima H, Tamai S, Mizumoto S, Inada Y. Vascularized fibular grafts in the treatment of osteomyelitis and infected nonunion. Clin Orthop Relat Res. 1993;293:256-64.
4. Safoury Y. Free vascularized fibula for the treatment of traumatic bone defects and nonunion of the forearm bones. J Hand Surg Br. 2005;30:67-72.
5. Szpalski M, Gunzburg R. Recombinant human bone morphogenetic protein-2: A novel osteoinductive alternative to autogenous bone graft? Acta Orthop Belg. 2005;71:133-48.
6. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-A(12): 2123-34.
7. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:1946-9.
8. Pauly S, Luttosch F, Morawski M, Haas NP, Schmidmaier G, Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone. 2009;45: 505-11.
9. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Nonlipid-related effects of statins. Ann Med. 2000;32:164-76.
10. Turner TM, Urban RM, Gitelis S, Kuo KN, Andersson GB. Radiographic and histologic assessment of calcium sulfate in experimental animal models and clinical use as a resorbable bone-graft substitute, a bone-graft expander, and a method for local antibiotic delivery. One institution's experience. J Bone Joint Surg Am. 2001;83-A(Suppl 2):8-18.
11. McKee MD, Wild LM, Schemitsch EH, Waddell JP. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: Early results of a prospective trial. J Orthop Trauma. 2002;16: 622-7.
12. Mousset B, Benoit MA, Delloye C, Bouillet R, Gillard J. Biodegradable implants for potential use in bone infection: An in vitro study of antibiotic-loaded calcium sulphate. Int Orthop. 1995;19:157-61.
13. Dacquet V, Varlet A, Tandogan RN, Tahon MM, Fournier L, Jehl F, et al. Antibiotic-impregnated plaster of Paris beads: Trials with teicoplanin. Clin Orthop Relat Res. 1992;282:241-9.
14. Benoit MA, Mousset B, Delloye C, Bouillet R, Gillard J. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int Orthop. 1997;21:403-8.
15. Dumas A, Moreau MF, Gherardi RK, Basle MF, Chappard D. Bone grafts cultured with bone marrow stromal cells for the repair of critical bone defects: An experimental study in mice. J Biomed Mater Res A. 2009;90:1218-29.
16. Giannoni P, Mastrogiacomo M, Alini M, Pearce SG, Corsi A, Santolini F, et al. Regeneration of large bone defects in sheep using bone marrow stromal cells. J Tissue Eng Regen Med. 2008;2:253-62.
17. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M, Martin I, et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res. 2000;49:328-37.
18. Zhou J, Lin H, Fang T, Li X, Dai W, Uemura T, et al. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. Biomaterials. 2010;31: 1171-9.
19. Ouyang HW, Toh SL, Goh J, Tay TE, Moe K. Assembly of bone marrow stromal cell sheets with knitted poly (L-lactide) scaffold for engineering ligament analogs. J Biomed Mater Res B Appl Biomater. 2005;75:264-71.
20. Yang J, Yamato M, Kohno C, Nishimoto A, Sekine H, Fukai F, et al. Cell sheet engineering: Recreating tissues without biodegradable scaffolds. Biomaterials. 2005;26:6415-22.
21. Nakamura A, Akahane M, Shigematsu H, Tadokoro M, Morita Y, Ohgushi H, et al. Cell sheet transplantation of cultured mesenchymal stem cells enhances bone formation in a rat nonunion model. Bone. 2010;46:418-24.
22. Akahane M, Nakamura A, Ohgushi H, Shigematsu H, Dohi Y, Takakura Y. Osteogenic matrix sheet-cell transplantation using osteoblastic cell sheet resulted in bone formation without scaffold at an ectopic site. J Tissue Eng Regen Med. 2008;2:196-201.
23. Nyan M, Miyahara T, Noritake K, Hao J, Rodriguez R, Kuroda S, et al. Molecular and tissue responses in the healing of rat calvarial defects after local application of simvastatin combined with alpha tricalcium phosphate. J Biomed Mater Res B Appl Biomater. 2010;93:65-73.
24. Ayukawa Y, Yasukawa E, Moriyama Y, Ogino Y, Wada H, Atsuta I, et al. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:336-42.
25. Wadagaki R, Mizuno D, Yamawaki-Ogata A, Satake M, Kaneko H, Hagiwara S, et al. Osteogenic induction of bone marrow-derived stromal cells on simvastatin-releasing, biodegradable, nano-to microscale fiber scaffolds. Ann Biomed Eng. 2011;39:1872-81.
26. Kupcsik L, Meurya T, Flury M, Stoddart M, Alini M. Statin-induced calcification in human mesenchymal stem cells is cell death related. J Cell Mol Med. 2009;13:4465-73.
27. Zhou Y, Ni Y, Liu Y, Zeng B, Xu Y, Ge W. The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma. Biomaterials. 2010;31:5325-35.
28. Baek KH, Lee WY, Oh KW, Tae HJ, Lee JM, Lee EJ, et al. The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells. J Korean Med Sci. 2005;20:438-44.
29. Maeda T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun. 2001;280: 874-7.
30. Ruiz-Gaspa S, Nogues X, Enjuanes A, Monllau JC, Blanch J, Carreras R, et al. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem. 2007;101:1430-8.
31. Viereck V, Grundker C, Blaschke S, Frosch KH, Schoppet M, Emons G, et al. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts. J Cell Biochem. 2005; 96:1244-53.
32. Sonobe M, Hattori K, Tomita N, Yoshikawa T, Aoki H, Takakura Y, et al. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells: Study of a new therapeutic agent for fracture. Biomed Mater Eng. 2005;15: 261-7.
33. Wong RW, Rabie AB. Statin collagen grafts used to repair defects in the parietal bone of rabbits. Br J Oral Maxillofac Surg. 2003;41:244-8.
34. Stein D, Lee Y, Schmid MJ, Killpack B, Genrich MA, Narayana N, et al. Local simvastatin effects on mandibular bone growth and inflammation. J Periodontol. 2005;76:1861-70.
35. Lee Y, Schmid MJ, Marx DB, Beatty MW, Cullen DM, Collins ME, et al. The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials. 2008;29:1940-9.
36. Woo JT, Nakagawa H, Krecic AM, Nagai K, Hamilton AD, Sebti SM, et al. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha). Biochem Pharmacol. 2005;69:87-95.
37. Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, et al. Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A. 1999;96:133-8.
38. Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation. 2002;105:739-45.
39. Maeda T, Kawane T, Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology. 2003;144: 681-92.
40. Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, et al. Hypoxia and VEGF upregulate BMP-2 mRNA and protein expression in microvascular endothelial cells: Implications for fracture healing. Plast Reconstr Surg. 2002;109:2384-97.
41. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology. 2002;143:1545-53.